palifermin (Kepivance)

From Aaushi

Jump to navigation Jump to search

^[1]

Introduction

Tradename: Kepivance

Indications

prevention of oral mucositis in selected patients preparing for bone marrow transplantation

Mechanism of action

keratinocyte growth factor

Notes

Manufacturer: Amgen

More general terms

References

↑ Prescriber's Letter 12(2): 2005 New Drugs Approved by the FDA in 2004 Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=210216&pb=PRL (subscription needed) http://www.prescribersletter.com

Retrieved from "https://aaushi.info/w/index.php?title=A5619&oldid=1166626"

↑ Back to top